DBX
Dropbox, Inc.
DBX's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over DBX overall, supported by stronger valuation and stronger modeled upside.
DBX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Stable |
DBX's profitability and cash flow are currently strong, and its revenue and balance sheet are stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
DBX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 10x | $33.51 | — |
| Cheap | 15x | $27.58 | -18% |
| Fair | 18x | $34.00 | +1.5% |
| Current | 18x | $33.51 | — |
| Expensive | 25x | $45.96 | +37% |
Historical ranges are pointers, not guarantees.
DBX's PE is in its fair range at 18x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over DBX in the historical PE scenario, which offers more potential upside but is not a forecast.
DBX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect DBX's earnings to grow and its profitability to improve, with its revenue holding steady.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
DBX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.25 | +76% |
| Q3 2026 | $1.85 | +5.1% |
| Q2 2026 | $1.80 | +10% |
| Q1 2026 | $1.83 | +20% |
| Q4 2025 | $1.86 | +33% |
| Q3 2025 | $1.76 | +2.3% |
| Q2 2025 | $1.63 | -4.7% |
| Q1 2025 | $1.52 | +1.3% |
| Q4 2024 | $1.40 | +6.9% |
DBX earned $1.85 per share over the past year, up 5.1% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over DBX on earnings, with more consistent year-over-year improvement.
DBX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $637.3M | +0.5% |
| Q2 2026 | $631.5M | +0.9% |
| Q1 2026 | $629.5M | +0.8% |
| Q4 2025 | $636.2M | -1.1% |
| Q3 2025 | $634.4M | -0.7% |
| Q2 2025 | $625.7M | -1.4% |
| Q1 2025 | $624.7M | -1% |
| Q4 2024 | $643.6M | +1.4% |
DBX's revenue grew through 2023 and has held roughly level since: $637M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 27% | -0.1 points |
| Q2 2026 | 26% | -0.8 points |
| Q1 2026 | 27% | -2 points |
| Q4 2025 | 26% | +12 points |
| Q3 2025 | 28% | +7.5 points |
| Q2 2025 | 27% | +6.9 points |
| Q1 2025 | 29% | +6.7 points |
| Q4 2024 | 14% | -28 points |
DBX's operating margin was 27% last quarter, about level with the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over DBX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over DBX on profitability, with a higher operating margin.
DBX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $251.8M | -14% |
| Q2 2026 | $235.2M | -9% |
| Q1 2026 | $203.3M | +32% |
| Q4 2025 | $224.9M | +6.8% |
| Q3 2025 | $293.7M | +8.7% |
| Q2 2025 | $258.5M | +15% |
| Q1 2025 | $153.7M | -7.6% |
| Q4 2024 | $210.5M | +11% |
DBX's free cash flow has been positive every quarter for seven years: $915M over the past year, about the same as the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over DBX on cash flow, with more consistent year-over-year improvement.
DBX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -1.7M shares |
| 1 year | -15% | -40M shares |
| 3 years | -35% | -121M shares |
| 5 years | -43% | -173M shares |
| Available history | -45% | -187M shares |
DBX has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $150.2M |
| Q2 2026 | $330.3M |
| Q1 2026 | $366.8M |
| Q4 2025 | $415M |
| Q3 2025 | $389.8M |
| Q2 2025 | $410M |
| Q1 2025 | $499.1M |
| Q4 2024 | $353.3M |
DBX spent $1.3B buying back its own shares over the past year, down 24% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
DBX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 0.7x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.6x | Net Cash |
DBX's net debt is about 1.8 years of its operating earnings (EBITDA), up from less than a year a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over DBX on leverage, with a lower net debt burden relative to earnings.
DBX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.7 | Neutral |
| Stochastic | 53.7 | Neutral |
DBX's weekly RSI is 53 (neutral) and its Stochastic is 54 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
DBX PE vs Technology Sector
| Metric | DBX | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 28x | 35% below |
| PE % | 44 | 35 | 9 pts above |
DBX has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
DBX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.8 | 3.7% below |
| 20 week MA | $33.7 | 0.7% below |
| 50 week MA | $29.1 | 15% above |
| 100 week MA | $29.0 | 16% above |
| 200 week MA | $27.1 | 24% above |
DBX has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
DBX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.7 | $24.7 | +39% |
| 2021 | $24.7 | $25.0 | +1.3% |
| 2022 | $25.0 | $22.5 | -10% |
| 2023 | $22.5 | $29.5 | +31% |
| 2024 | $29.5 | $30.5 | +3.5% |
| 2025 | $30.5 | $28.0 | -8.3% |
| 2026 YTD | $28.0 | $33.5 | +20% |
DBX has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.